We love dividend stocks here (if it's not already obvious). Companies that regularly give investors a share of their earnings through payouts come from...
Biotech stocks began the year with gusto, but sold off when the broader-market rally fizzled in February, as investors sought safer havens. Yet, with...
Stocks edged higher this morning amid easing concerns about the debt ceiling as negotiations in Washington gained steam. According to Oppenheimer’s John Stoltzfus, investors...